Dedifferentiated Chondrosarcoma — Trials

Dedifferentiated Chondrosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–4 of 4 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01267955	Vismodegib in Treating Patients With Advanced Chondrosarcomas	active not recruiting	Phase 2	45	National Cancer Institute (NCI)NIH	1	Aug 13, 2026	clinicaltrials
NCT04458922	Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma	active not recruiting	Phase 2	27	National Cancer Institute (NCI)NIH	2	Jul 31, 2026	clinicaltrials